SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-088543
Filing Date
2024-08-12
Accepted
2024-08-12 21:47:05
Documents
2
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2420079-3_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2420079-3_3seq1.xml 3 4369
2 EXHIBIT 24 tm2420079d3_ex24.htm EX-24 3104
  Complete submission text file 0001104659-24-088543.txt   9039
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Issuer) CIK: 0001652935 (see all company filings)

IRS No.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address
Mazar Andrew Paul (Reporting) CIK: 0001727393 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42139 | Film No.: 241198554